DHJJ Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.66K Hold
35
﹤0.01% 646
2026
Q1
$5.91K Hold
35
﹤0.01% 643
2025
Q4
$5.91K Hold
35
﹤0.01% 609
2025
Q3
$5.05K Hold
35
﹤0.01% 615
2025
Q2
$4.43K Hold
35
﹤0.01% 618
2025
Q1
$4.48K Hold
35
﹤0.01% 578
2024
Q4
$4.63K Hold
35
﹤0.01% 559
2024
Q3
$5.1K Hold
35
﹤0.01% 544
2024
Q2
$4.8K Hold
35
﹤0.01% 510
2024
Q1
$4.8K Hold
35
﹤0.01% 503
2023
Q4
$4.75K Hold
35
﹤0.01% 494
2023
Q3
$4.28K Buy
+35
New +$4.45K ﹤0.01% 501

Other funds holding IBB

DHJJ Financial Advisors's IBB Position: Q2 2026 in Review

DHJJ Financial Advisors held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 35 shares worth $6.66K. The position accounts for ﹤0.01% of the portfolio, ranked #646.

DHJJ Financial Advisors first reported a position in IBB in Q3 2023 and has held it in 12 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • DHJJ Financial Advisors held 35 shares of iShares Biotechnology ETF worth $6.66K as of Q2 2026.
  • DHJJ Financial Advisors left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of DHJJ Financial Advisors's portfolio in Q2 2026, its #646 holding.
  • DHJJ Financial Advisors first reported a position in iShares Biotechnology ETF in Q3 2023 and has held it in 12 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on DHJJ Financial Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.